The next evolution of Signature Intelligence.
SarborgQ represents the next chapter for the Company's Signature Intelligence platform. We are applying quantum computing to understand the underlying mechanistic architecture of biological systems, and ultimately to design entirely new solutions.
Mechanism is the next frontier.
The existing Sarborg platform is designed to identify and rank opportunities by analysing biological signatures and comparing them against proprietary databases. It is a powerful engine for discovery, but it operates primarily in the realm of correlation and pattern matching.
SarborgQ advances this further. We proceed on the basis that understanding the mechanistic architecture of biological systems is the next frontier in computational biology. Knowing what is connected is valuable. Understanding why it is connected, and how those connections propagate through complex networks, is transformative.
Quantum computing provides unique advantages in solving these highly complex network problems. Biological systems are not merely large datasets; they are deeply entangled networks of interactions where classical computational methods struggle to scale. Quantum-native algorithms can explore these spaces in ways that were previously unreachable.
What SarborgQ will deliver.
Mechanistic Architecture
SarborgQ moves beyond signature matching to understand why biological systems behave as they do. Quantum computing enables the analysis of complex mechanistic networks at a scale impossible with classical methods.
Network Complexity
Biological systems are fundamentally network problems, where genes, proteins, pathways, and metabolites interact in highly entangled ways. Quantum algorithms provide unique advantages in solving these combinatorial challenges.
Designed Solutions
Understanding mechanism is the prerequisite for design. SarborgQ aims not only to identify opportunities but to engineer entirely new biological and chemical solutions from first principles.
From the Sarborg platform to SarborgQ.
From identifying correlations between drug and disease signatures to understanding the mechanistic architecture that drives biological outcomes.
From surfacing and scoring existing assets to generating novel compounds, targets, and interventions designed for specific biological contexts.
From conventional algorithms bounded by classical complexity to quantum-native approaches that exploit superposition and entanglement for network analysis.
"Quantum computing provides unique advantages in solving highly complex network problems, and biological systems are the most complex networks we know."
SarborgQ proceeds on this basis: that the mechanistic architecture of biology is not merely harder to compute, but qualitatively different. It demands a new kind of machine.
Strategic funding secured.
On 18 June 2026, Sarborg announced the closing of funding via a subscription agreement from a New York-based private investment fund at $125,000 per share, implying a fully diluted valuation of approximately $638.3 million.
Proceeds from the subscription will be used to establish SarborgQ, a new wholly-owned subsidiary dedicated to applying quantum computing to the Company's Signature Intelligence platform.
This represents a significant step forward in Sarborg's mission to decode biological signatures into actionable intelligence, and now, into designed solutions.
The future of discovery is quantum-native.
SarborgQ is building the bridge between quantum computing and biological intelligence. Get in touch to learn more.